Cannabis Bioscience International Holdings, Inc.
CBIH
$0.00
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 123.70K | 127.40K | 148.30K | 303.00K | 343.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 123.70K | 127.40K | 148.30K | 303.00K | 343.90K |
| Cost of Revenue | 26.10K | 42.50K | 39.80K | 40.10K | 45.50K |
| Gross Profit | 97.50K | 84.80K | 108.40K | 262.80K | 298.40K |
| SG&A Expenses | 484.20K | 507.60K | 495.10K | 672.40K | 614.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 510.50K | 550.20K | 535.00K | 712.50K | 660.10K |
| Operating Income | -387.00K | -422.90K | -386.60K | -409.40K | -316.00K |
| Income Before Tax | -515.20K | -592.50K | -555.00K | -548.70K | -472.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.52 | -0.59 | -0.56 | -0.55 | -0.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -515.20K | -592.50K | -555.00K | -548.70K | -472.90K |
| EBIT | -387.00K | -422.90K | -386.60K | -409.40K | -316.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 46.02B | 45.12B | 43.99B | 42.83B | 42.00B |
| Average Diluted Shares Outstanding | 46.02B | 45.12B | 43.99B | 42.83B | 42.00B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |